Osteopore Ltd. Stock Analysis OSX.AX

Osteopore Ltd. engages in the development and marketing of bioresorbable polymer implants for neurosurgical, orthopaedic and maxillofacial surgeries. The Company’s commercialized products are designed to enable natural bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. Through its proprietary manufacturing process, which uses a naturally dissolving polymer, its patented scaffolds enable bone tissue growth, significantly reducing the post-surgery complications commonly associated with permanent bone implants. The Company’s surgical specialty includes craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, and immediate implant loading, among others.